Monotype India

Which are the latest news on Monotype India?

Why is Monotype India Ltd falling/rising?

As of 05-Sep, Monotype India Ltd's stock price is at 0.30, unchanged from the previous day, and has seen a significant decline of 33.33% year-to-date and 50.00% over the past year, underperforming compared to the Sensex. The stock is trading below all moving averages, indicating a bearish trend and declining investor interest.

As of 05-Sep, Monotype India Ltd's stock price is currently at 0.30, showing no change from the previous day. The stock has been experiencing a downward trend, as evidenced by its performance over various periods. Over the past week, the stock has decreased by 6.25%, and in the last month, it has fallen by 11.76%. Year-to-date, the decline is significant at 33.33%, and over the past year, the stock has dropped by 50.00%. <BR><BR>In comparison to the benchmark Sensex, which has only decreased by 10.21% year-to-date, Monotype India Ltd's performance is notably worse. Additionally, the stock is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. <BR><BR>Investor participation has also declined, with a delivery volume of 10.03 lacs on September 3, which is down by 15.61% compared to the 5-day average. This reduction in trading activity suggests a lack of interest from investors, further contributing to the stock's decline. Overall, the combination of poor performance relative to the market, declining investor participation, and trading below moving averages indicates that Monotype India Ltd is currently experiencing a falling stock price.

Who are in the management team of Monotype India?

The management team of Monotype India includes Naresh Manakchand Jain (Whole-time Director), Suryakant Maruti Kadakane (Independent Director), Preeti Doshi (Independent Director), and Rajendra Redekar (Director and Additional Independent Director).

The management team of Monotype India includes the following individuals:<BR><BR>1. Naresh Manakchand Jain - Whole-time Director<BR>2. Suryakant Maruti Kadakane - Independent Director<BR>3. Preeti Doshi - Independent Director<BR>4. Rajendra Redekar - Director<BR>5. Rajendra Redekar - Additional Independent Director<BR><BR>If you need more information about their roles or contributions, feel free to ask!

What does Monotype India do?

Monotype India Ltd, a micro-cap company incorporated in 1974, engages in trading shares and financial services. As of June 2026, it reported a net profit of 0 Cr and has a market cap of INR 22 Cr.

Overview:<BR>Monotype India Ltd is engaged in trading in shares, financial services, and investment activities within the diversified commercial services industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Monotype India Ltd was incorporated on 30th September 1974 in Calcutta and was converted into a public limited company on 23rd October 1976. The latest quarterly results reported are for June 2026, showing a net profit of 0 Cr.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: 0 Cr (Quarterly Results - Jun 2026)<BR>Market-cap value: INR 22 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 3.00<BR>Industry P/E: 21<BR>Dividend Yield: 0.00%<BR>Debt-Equity: -4.29<BR>Return on Equity: -280.72%<BR>Price to Book: -10.09<BR><BR>Contact Details:<BR>Address: 602 6 Th floor Raheja Chambers, 213 Nariman Point Mumbai Maharashtra : 400001<BR>Tel: 022-40068190/91<BR>Email: monotypeindialtd@gmail.com<BR>Website: http://www.monotypeindia.in

Who are the peers of the Monotype India?

Monotype India's peers include ERP Soft Systems, Johnson Pharma, Shreevatsaa Fin., Enbee Trade, Vrundavan Planta, Samyak Internati, Rapid Invest., S I Cap. & Fin., and Greencrest Finan. Key insights show that Enbee Trade and Greencrest Finan exhibit excellent growth, while Monotype India has a 1-year return of -48.33%, lower than Johnson Pharma's -40.26%.

Peers: The peers of Monotype India are ERP Soft Systems, Johnson Pharma, Shreevatsaa Fin., Enbee Trade, Vrundavan Planta, Samyak Internati, Rapid Invest., S I Cap. & Fin., and Greencrest Finan.<BR><BR>Quality Snapshot: Below Average management risk is observed at ERP Soft Systems, Johnson Pharma, Enbee Trade, Vrundavan Planta, Samyak Internati, Rapid Invest., S I Cap. & Fin., and Greencrest Finan, while Shreevatsaa Fin. does not qualify. Average growth is found at Johnson Pharma and Samyak Internati, while Excellent growth is observed at Enbee Trade and Greencrest Finan, with the rest having Below Average or not qualifying. Good capital structure is noted at ERP Soft Systems, Vrundavan Planta, S I Cap. & Fin., while Excellent capital structure is seen at Enbee Trade, Samyak Internati, Rapid Invest., and Greencrest Finan, with the rest not qualifying.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Vrundavan Planta at N/A, while Johnson Pharma has the lowest at -40.26%, and Monotype India's own 1-year return is -48.33%, which is lower than Johnson Pharma's. Additionally, peers such as Enbee Trade, Johnson Pharma, and Monotype India have negative six-month returns.

How big is Monotype India?

As of 31st August, Monotype India Ltd has a market capitalization of 22.00 Cr, classifying it as a Micro Cap company, with reported Net Sales of 0.00 Cr and a Net Profit loss of 0.76 Cr in the latest four quarters.

As of 31st August, Monotype India Ltd has a market capitalization of 22.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Monotype India reported Net Sales of 0.00 Cr and a Net Profit loss of 0.76 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds at a loss of 1.65 Cr and Total Assets valued at 7.41 Cr.

Should I buy, sell or hold Monotype India Ltd?

Are Monotype India Ltd latest results good or bad?

Monotype India Ltd's latest results are concerning, showing a net loss of -₹0.22 crore and zero revenue in Q4 FY26, indicating a complete operational shutdown. The company faces significant solvency issues with negative shareholder funds and a one-year stock return of -39.44%, raising serious questions about its future viability.

The latest results for Monotype India Ltd are quite concerning. In Q4 FY26, the company reported a net profit of -₹0.22 crore, a significant decline from a profit of ₹6.63 crore in the same quarter of the previous year. Additionally, revenue fell to zero, marking a 100% year-on-year decrease, which indicates a complete operational shutdown.<BR><BR>The financial performance shows a troubling trend, with four consecutive quarters of zero revenue in FY26, compared to ₹13.55 crore in Q4 FY25. This operational collapse has led to negative shareholder funds of -₹1.65 crore, reflecting serious solvency issues.<BR><BR>Moreover, the company's stock has underperformed significantly, with a one-year return of -39.44%, compared to a decline of only 8.40% in the Sensex. The negative book value per share of -₹0.02 further complicates the situation, as it suggests that the company's liabilities exceed its assets.<BR><BR>Overall, the results indicate a distressed company facing critical challenges, including operational paralysis and negative equity, which raises serious questions about its future viability.

When is the next results date for Monotype India Ltd?

The next results date for Monotype India Ltd is 13 August 2026.

The next results date for Monotype India Ltd is scheduled for 13 August 2026.

How has been the historical performance of Monotype India?

Monotype India has shown significant recovery in financial performance, with net sales increasing from 4.58 Cr in Mar'24 to 61.97 Cr in Mar'25 and operating profit rising to 12.57 Cr. However, the company still faces challenges with negative total reserves of -71.96 Cr and fluctuating asset values.

Answer:<BR>The historical performance of Monotype India shows significant fluctuations in its financial metrics over the years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Monotype India's net sales have seen a notable increase from Mar'24 to Mar'25, rising from 4.58 Cr to 61.97 Cr, while the previous years showed varying results, including a peak of 210.34 Cr in Mar'18. The total operating income also reflects this trend, increasing to 61.97 Cr in Mar'25 from 4.58 Cr in Mar'24. Operating profit (PBDIT) has improved significantly, reaching 12.57 Cr in Mar'25 compared to 9.28 Cr in Mar'24, marking a recovery from previous losses. Profit before tax and profit after tax also showed positive growth, with figures of 12.57 Cr and 12.56 Cr respectively in Mar'25, indicating a strong turnaround from negative values in earlier years. However, the company continues to face challenges with total reserves remaining negative at -71.96 Cr in Mar'25, though this is an improvement from -84.52 Cr in Mar'24. The total liabilities decreased to 7.41 Cr in Mar'25 from 9.86 Cr in Mar'24, while total assets also declined to 7.41 Cr in Mar'25 from 9.86 Cr in Mar'24. Cash flow from operating activities was stable at 7.00 Cr in Mar'25, although cash flow from financing activities showed an outflow of -7.00 Cr. Overall, Monotype India has demonstrated a recovery in sales and profitability, but it still grapples with negative reserves and fluctuating asset values.

Is Monotype India overvalued or undervalued?

As of June 20, 2023, Monotype India is considered undervalued with a low PE ratio of 3.97 and an EV to EBITDA of 4.68, but it has moved to a "risky" classification due to a significant year-to-date decline of 61.75%, highlighting the need for caution despite its growth potential.

As of 20 June 2023, Monotype India has moved from a grade of "does not qualify" to "risky." The company is currently considered undervalued, primarily due to its low valuation ratios. Key ratios include a PE ratio of 3.97, an EV to EBITDA of 4.68, and a PEG ratio of 0.11, indicating significant potential for growth relative to its price.<BR><BR>In comparison to its peers, Monotype India stands out with a much lower PE ratio than Life Insurance at 12.54 and Bajaj Finance at 35.01, both of which are categorized as fairly valued and very expensive, respectively. The company's return metrics have been concerning, with a year-to-date decline of 61.75% compared to a 5.62% increase in the Sensex, highlighting the volatility and risk associated with the stock. Overall, while Monotype India is undervalued based on its ratios, the risks associated with its current valuation and performance should be carefully considered.

What is the technical trend for Monotype India?

As of May 12, 2025, Monotype India shows a mildly bearish technical trend, with bearish Bollinger Bands and moving averages, despite some mixed signals from the MACD and KST.

As of 12 May 2025, the technical trend for Monotype India has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The Bollinger Bands are bearish on both weekly and monthly time frames, and daily moving averages are also bearish. The KST shows a mildly bullish stance weekly but is mildly bearish monthly. There are no clear trends indicated by Dow Theory on either time frame. Overall, the current technical stance is mildly bearish, driven primarily by the bearish Bollinger Bands and moving averages, despite some mildly bullish signals from the MACD and KST on the weekly chart.

Who are the top shareholders of the Monotype India?

The top shareholders of Monotype India are Sandeep Ispat Trader LLP with 10.8%, Vedant Commodeal Private Limited at 3.91%, and individual investors holding 67.1%. There are no pledged promoter holdings, and the company has no mutual fund or foreign institutional investor involvement.

The top shareholders of Monotype India include Sandeep Ispat Trader LLP, which holds the highest promoter stake at 10.8%. The highest public shareholder is Vedant Commodeal Private Limited, with a holding of 3.91%. Additionally, individual investors collectively hold a significant portion of 67.1%. There are no pledged promoter holdings, and the company does not have any mutual fund or foreign institutional investor (FII) involvement.

Has Monotype India declared dividend?

No Dividend History Available